Gunderson Dettmer Represented Hims & Hers in GRAIL $325M PIPE

Gunderson Dettmer represented client Hims & Hers in its participation in the $325 million private investment in public equity (PIPE) transaction for GRAIL, a publicly traded healthcare company whose mission is to detect cancer early when it can be cured.

GRAIL’s targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL currently expects to use the net proceeds from the private placement to fund its commercial activities and reimbursement efforts, as well as for working capital and other general corporate purposes.

The Gunderson deal team was led by Alexa Belonick and Keith Scherer and included Elena Vespoli and John Maciejewski.

Companies
Hims & Hers
GRAIL